Do you have any evidence, even anecdotal, on major manufacturers trashing the potential of two bath developers based on their own research? Haist thought it was worthwhile to discuss two bath development in his book. I didn't see him drawing any conclusions like you in his book.
At best he provides a literature overview in that segment - and no current analysis. You have to be careful reading Haist because as much as he provides an overview of processes, he meticulously avoids (other than hinting at) commercially sensitive technology/ knowledge that only becomes clearer when you read alongside later work - such as Ron's (who was one of the peer reviewers/ censors of Haist's book) - and other patents, academic publications/ papers, theses of the era. It's a book written for a reader wanting a large-scale overview of the processes at a fairly good technical level, not necessarily for someone who's 'skilled in the specifics of the arcane art' - if it was written at the latter level it would probably have been 10x the size, and probably unpublishable at the time because of the level of commercial sensitivity - there's not much discussion of the use or exploitation of inhibition effects, for example - which we now know to have been under intense R&D at the time. You also have to remember that the culture Haist's book came from didn't necessarily want to tell third parties without large research staffs how to improve their competing products (and those with significant R&D staff had likely pretty quickly worked out what Kodak was doing anyway). There is no doubt that a two bath system can potentially provide a decently optimised development system for a given emulsion/ contrast index - but so could a monobath system, and that seems to have been where Haist saw greater potential. There's nothing particularly 'magical' about 2-bath developers, and the increased complexity of having to maintain multiple 2nd baths to control contrast rapidly becomes impractical - as opposed to simply adjusting the development time of a single developing solution - and/ or using emulsion based approaches to dealing with contrast variance (variable contrast papers for example) - all of which are far more universal in applicability than a 2-bath system.
Can you expand on this with examples from their product range
The varying evolutions of Ultrafin for a start - which now seem to have settled down into conventional two developing-agent formulae, rather than 3. And the other ingredient choices for Ultrafin T-plus & Neotenal pretty closely reflect what most of the high-tech developers aimed at more modern emulsions headed towards.